Memantine Hydrochloride NDC 50090-5832

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-5832Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-5832Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50090-5832-0	50090583200	90 TABLET in 1 BOTTLE (50090-5832-0)Marketed from Oct 27, 2021
50090-5832-1	50090583201	60 TABLET in 1 BOTTLE (50090-5832-1)Marketed from Mar 1, 2022
50090-5832-2	50090583202	180 TABLET in 1 BOTTLE (50090-5832-2)Marketed from Mar 1, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine Hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202840
Marketing start: Oct 13, 2015
Listing expires: Dec 31, 2026
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 50090-5832_fdbbca96-290b-4c82-b8ca-3f27106a5921SPL ID fdbbca96-290b-4c82-b8ca-3f27106a5921SPL set ID 66db6d61-cf1d-46ca-a645-19e9a20f4617RxCUI 996561UNII JY0WD0UA60
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090583200 followed by a unit qualifier and the quantity

Package 50090-5832-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 24, 2023.

Indications (excerpt from the label)

Memantine hydrochloride USP is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202840

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202840
Product	Strength	Form · route	Labeler	Product NDC
Memantine Hydrochloride	Memantine hydrochloride 5 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-297
Memantine Hydrochloride	Memantine hydrochloride 10 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-298